Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 3, 2013, Pages 530-536

  Honda, Yohji ^a   Kimura, Tomoki ^a   Aikata, Hiroshi ^a   Kobayashi, Tomoki ^a   Fukuhara, Takayuki ^a   Masaki, Keiichi ^a   Nakahara, Takashi ^a   Naeshiro, Noriaki ^a   Ono, Atsushi ^a   Miyaki, Daisuke ^a   Nagaoki, Yuko ^a   Kawaoka, Tomokazu ^a   Takaki, Shintaro ^a   Hiramatsu, Akira ^a   Ishikawa, Masaki ^a   Kakizawa, Hideaki ^a   Kenjo, Masahiro ^a   Takahashi, Shoichi ^a   Awai, Kazuo ^a   Nagata, Yasushi ^a   Chayama, Kazuaki ^a   more..

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

HCC; Hypervascular; SBRT; Solitary; TACE

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; HEMOGLOBIN;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER CONTROL; CHEMOEMBOLIZATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERBILIRUBINEMIA; LEUKOPENIA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; THERAPY EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VOLUME;

EID: 84874372382     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12087     Document Type: Article

References (34)

1. Nakano M, Ando E, Sato M etal. Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan. Hepatol. Res. 2010; 40: 989-996.
2. Arii S, Sata M, Kudo M etal. Management of hepatocellular carcinoma: report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol. Res. 2010; 40: 667-685.
3. Okita K. Management of hepatocellular carcinoma in Japan. J. Gastroenterol. 2006; 41: 100-106.
4. Bruix J, Llovet JM. Major achievements in hepatocellular carcinoma. Lancet 2009; 373: 614-616.
5. Kamada K, Kitamoto M, Chayama K etal. Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutan eous ethanol injection for treatment of advanced small hepatocellular carcinoma. Am. J. Surg. 2002; 184: 284-290.
6. Kawaoka T, Aikata H, Chayama K etal. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma. Cardiovasc. Intervent. Radiol. 2009; 32: 684-694.
7. Takayasu K, Arii S, Yamaoka Y etal. Liver Cancer Study Group of Japan. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006; 131: 461-469.
8. Arii S, Yamaoka Y, Futagawa S etal. Results of surgical and nonsurgical treatment for small sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32: 1224-1229.
9. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.
10. Song TJ, Ip EW, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology 2004; 127: 248-260.
11. Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004; 10: 115-120.
12. Waki K, Aikata H, Cyayama K etal. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up. J. Gastroenterol. Hepatol. 2010; 25: 597-604.
13. Shiina S, Teratani T, Obi S etal. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-130.
14. Goldberg SN, Grassi CJ, Cardella JF etal. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005; 235: 728-739.
15. Schefter TE, Cardenes HR, Kavanagh BD. Stereotactic body radiation therapy for liver tumors. In: Kavanagh BD, Timmerman RD, eds. Stereotactic Body Radiation Therapy. Philadelphia: Lippincott Williams & Wilkins, 2005; 115-127.
16. Dawson LA, Jaffray DA. Advances in image-guided radiation therapy. J. Clin. Oncol. 2007; 25: 938-946.
17. Tse RV, Hawkins M, Lockwood G etal. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J. Clin. Oncol. 2008; 26: 3911-3912.
18. Kimura T, Hirokawa Y, Murakami Y etal. Reproducibility of organ position using voluntary breath-hold with spirometer for extracranial stereotactic radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2004; 60: 1307-1313.
19. Kudo M, Kubo S, Takayasu K etal. Response evaluation criteria in cancer of the liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version). Hepatol. Res. 2010; 40: 686-692.
20. Normolle D, Balter JM etal. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int. J. Radiat. Oncol. Biol. Phys. 2002; 53: 810-821.
21. Liang SX, Zhu XD, Xu ZY etal. Radiation-induced liver disease in three-dimensional conformal radiotherapy for primary liver carcinoma. The risk factors and hepatic radiation tolerance. Int. J. Radiat. Oncol. Biol. Phys. 2006; 65: 426-434.
22. Kudo M, Izumi N, Kokudo N etal. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig. Dis. 2011; 29: 339-364.
23. Andolino DL, Johnson CS, Cardenes HP etal. Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2011; 81: 447-453.
24. Choi BO, Jang HS, Choi IB etal. Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma. Jpn. J. Clin. Oncol. 2006; 36: 154-158.
25. Sato M, Uematsu M, Fukui T etal. Feasibility of frameless stereotactic high dose radiation therapy for primary or metastatic liver cancer. J. Radiosurg. 1998; 1: 233-238.
26. Herfarth KK, Debus J, Lorth F etal. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J. Clin. Oncol. 2001; 19: 164-170.
27. Cheng S, Huang A. Liver and hepatobiliary tract. In: Perez C, Brady L, Halperin E, Schmidt-Ullrich R, eds. Principles and Practice of Radiation Oncology, 4th edn. Philadelphia: Lippincott Williams &Wilkins, 2004; 1589-1606.
28. Wu DH, Liu L, Chen LH. Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. World J. Gastroenterol. 2004; 10: 2184-2189.
29. Park HC, Seong J, Han KH etal. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2002; 54: 150-155.
30. Price TR, Perkins SM, Sandrasegaran K etal. Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma. Cancer 2012; 118: 3191-3198.
31. Fajardo LF, Anderson RE, Berthrong M etal. Radiation Pathology. Oxford, UK: Oxford University Press, 2011; 249-257.
32. Izawa H, Hirowatari H, Sasai K etal. Effect of dose fractionation on pulmonary complications during total body irradiation. J. Radiat. Res. 2011; 52: 502-508.
33. Byfield JE, Lynch M, Kulhainan F etal. Cellular effects of combined adriamycin and x-irradiation in human tumor cells. Int. J. Cancer 1977; 19: 194-204.
34. Rotman M, Aziz H, Wasserman T. Chemotherapy and Irradiation. Principle and Practice of Radiation Oncology, 3rd edn. Philadelphia, PA: Lippincot-Raven Publishers, 1997; 705-722.